Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis

Arthritis and Rheumatism

Volumn 60, Issue 9, 2009, Pages 2830-2838

  Abdulahad, Wayel H ^a   Kallenberg, Cees G M ^a   Limburg, Pieter C ^a   Stegeman, Coen A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ACTIVITY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; INFLAMMATION; KIDNEY CELL; KIDNEY DISEASE; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REMISSION; URINE LEVEL; URINE SEDIMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; VASCULITIS;

EID: 69449091010     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24747     Document Type: Article

References (34)

1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-1523
2. Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-558
3. Kallenberg CG. Churg-Strauss syndrome: just one disease entity? [editorial]. Arthritis Rheum 2005;52:2589-2593
4. Gephardt GN, Ahmad M, Tubbs RR. Pulmonary vasculitis (Wegener's granulomatosis): immunohistochemical study of T and B cell markers. Am J Med 1983;74:700-704
5. Ten Berge IJ, Wilmink JM, Meyer CJ, Surachno J, ten Veen KH, Balk TG, et al. Clinical and immunological follow-up of patients with severe renal disease in Wegener's granulomatosis. Am J Nephrol 1985;5:21-29
6. Bolton WK, Innes DJ Jr, Sturgill BC, Kaiser DL. T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. Kidney Int 1987;32:869-876
7. Lockwood CM, Thiru S, Stewart S, Hale G, Isaacs J, Wraight P, et al. Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. QJM 1996;89:903-912 (Pubitemid 27016320)
8. Hagen EC, de Keizer RJ, Andrassy K, van Boven WP, Bruijn JA, van Es LA, et al. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin. Clin Nephrol 1995;43:351-359
9. + effector memory T cells in Wegener's granulomatosis. Kidney Int 2006;70:938-947
10. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007;56:2080-2091
11. Abdulahad WH, Stegeman CA, Limburg PC, Kallenberg CG. CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann N Y Acad Sci 2007;1107:22-31.
12. Sakatsume M, Xie Y, Ueno M, Obayashi H, Goto S, Narita I, et al. Human glomerulonephritis accompanied by active cellular infiltrates shows effector T cells in urine. J Am Soc Nephrol 2001;12:2636-2644 (Pubitemid 33115410)
13. Deenitchina SS, Ando T, Akazawa K, Hirakata H, Fujishima M. Prediction of the clinical and histological severity of IgA nephropathy by flow cytometry of urinary mononuclear cells. Clin Exp Nephrol 1999;3:272-278 (Pubitemid 30022533)
14. Grunewald RW, Fiedler GM, Stock B, Grunewald JM, Muller GA. Immunocytological determination of lymphocytes and monocytes/macrophages in urinary sediments of renal allograft recipients. Nephrol Dial Transplant 2000;15:888-892 (Pubitemid 30312013)
15. Chan RW, Lai FM, Li EK, Tam LS, Chung KY, Chow KM, et al. Urinary mononuclear cell and disease activity of systemic lupus erythematosus. Lupus 2006;15:262-267 (Pubitemid 43828801)
16. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-678 (Pubitemid 24334817)
17. Viglietta V, Kent SC, Orban T, Hafler DA. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes [published erratum appears in J Clin Invest 2002;109:1511]. J Clin Invest 2002;109:895-903. (Pubitemid 34596177)
18. + channel in effector memory T cells as new target for MS [published erratum appears in J Clin Invest 2003;112:298]. J Clin Invest 2003;111:1703-1713
19. Burns J, Bartholomew B, Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999;45:33-39 (Pubitemid 29036429)
20. Beeton C, Wulff H, Standifer NE, Azam P, Mullen KM, Pennington MW, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 2006;103:17414-17419 (Pubitemid 44788983)
21. Friedrich M, Krammig S, Henze M, Docke WD, Sterry W, Asadullah K. Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch Dermatol Res 2000;292:519-521 (Pubitemid 32112810)
22. + memory T cells homing to the joints in juvenile idiopathic arthritis. Arthritis Res Ther 2005;7:R256-67.
23. Shiao SL, Kirkiles-Smith NC, Shepherd BR, McNiff JM, Carr EJ, Pober JS. Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo. J Immunol 2007;179:4397-4404
24. Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, et al. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 2006;17:1940-1949 (Pubitemid 44036178)
25. Hayry P, von Willebrand E, Andersson LC. Expression of HLAABC and -DR locus antigens on human kidney, endothelial, tubular and glomerular cells. Scand J Immunol 1980;11:303-310 (Pubitemid 10149768)
26. + T cells. J Immunol 1999;162:696-703.
27. + CTLs ex vivo. J Immunol 2002;168:5954-5958
28. Van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004;173:6719-6726 (Pubitemid 39541057)
29. Snyder MR, Weyand CM, Goronzy JJ. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol 2004;25:25-32.
30. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002;105:570-575 (Pubitemid 34123430)
31. Choy JC, Cruz RP, Kerjner A, Geisbrecht J, Sawchuk T, Fraser SA, et al. Granzyme B induces endothelial cell apoptosis and contributes to the development of transplant vascular disease. Am J Transplant 2005;5:494-499 (Pubitemid 40313340)
32. Choy JC, Kerjner A, Wong BW, McManus BM, Granville DJ. Perforin mediates endothelial cell death and resultant transplant vascular disease in cardiac allografts. Am J Pathol 2004;165:127-133 (Pubitemid 38821820)
33. + T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 2007;132:2346-2358
34. Holmen C, Elsheikh E, Stenvinkel P, Qureshi AR, Pettersson E, Jalkanen S, et al. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol 2005;16:3110-3120 (Pubitemid 44743509)